SCHEMBL15380924

SCHEMBL15380924

Cn1c(Nc2cc(CNC3(C)CCCCC3)ccc2Cl)nc2cc(C(=O)NCCN3CCCCC3)ccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.42
PTGES O14684 1/20 0.42
KMT2A Q03164 4/20 0.42
MEN1 O00255 3/20 0.42
CACNA1G O43497 4/20 0.41
IKBKB O14920 2/20 0.41
TP53 P04637 3/20 0.41
MAPT P10636 2/20 0.41
ALDH1A1 P00352 2/20 0.41
PDE2A O00408 1/20 0.41
PDE10A Q9Y233 1/20 0.41
POLB P06746 1/20 0.41
LMNA P02545 1/20 0.40
SUV39H1 O43463 1/20 0.40
CHUK O15111 1/20 0.40
MAPK10 P53779 1/20 0.40
GAA P10253 1/20 0.40
GFER P55789 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CSNK2A2 P19784 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3108313 0.92 PTGES (0.43) HDAC6PTGESKMT2AMEN1CACNA1G
SCHEMBL15380429 0.88 PTGES (0.45) HDAC6PTGESTP53MAPTPOLB
SCHEMBL3094243 0.87 IDH1 (0.44) PTGESKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL15380913 0.84 KMT2A (0.46) PTGESKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL11894984 0.82 PTGES (0.47) HDAC6PTGESKMT2AMEN1TP53
SCHEMBL3100803 0.81 PTGES (0.54) HDAC6PTGESALDH1A1
SCHEMBL3109449 0.81 PTGES (0.54) HDAC6PTGESALDH1A1
SCHEMBL3112010 0.81 PTGES (0.44) HDAC6PTGESKMT2AMEN1TP53
SCHEMBL3094236 0.80 PTGES (0.45) PTGESKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL3099237 0.80 PTGES (0.46) PTGESKMT2AMEN1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8921405-B2 Compounds OREXO AB (SE) 2014-12-30 US disclosed
US-20130303571-A1 NEW COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-11-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130303571-A1 NEW COMPOUNDS MTX1, LTB4R, RDX HDAC6 460/4885PTGES 307/4885KMT2A 3186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.